Literature DB >> 32964285

TRPM7 channel activity in Jurkat T lymphocytes during magnesium depletion and loading: implications for divalent metal entry and cytotoxicity.

Alayna Mellott1, Jananie Rockwood1, Tetyana Zhelay1, Charles Tuan Luu1, Taku Kaitsuka2, J Ashot Kozak3.   

Abstract

TRPM7 is a cation channel-protein kinase highly expressed in T lymphocytes and other immune cells. It has been proposed to constitute a cellular entry pathway for Mg2+ and divalent metal cations such as Ca2+, Zn2+, Cd2+, Mn2+, and Ni2+. TRPM7 channels are inhibited by cytosolic Mg2+, rendering them largely inactive in intact cells. The dependence of channel activity on extracellular Mg2+ is less well studied. Here, we measured native TRPM7 channel activity in Jurkat T cells maintained in external Mg2+ concentrations varying between 400 nM and 1.4 mM for 1-3 days, obtaining an IC50 value of 54 μM. Maintaining the cells in 400 nM or 8 μM [Mg2+]o resulted in almost complete activation of TRPM7 in intact cells, due to cytosolic Mg2+ depletion. A total of 1.4 mM [Mg2+]o was sufficient to fully eliminate the basal current. Submillimolar concentrations of amiloride prevented cellular Mg2+ depletion but not loading. We investigated whether the cytotoxicity of TRPM7 permeant metal ions Ni2+, Zn2+, Cd2+, Co2+, Mn2+, Sr2+, and Ba2+ requires TRPM7 channel activity. Mg2+ loading modestly reduced cytotoxicity of Zn2+, Co2+, Ni2+, and Mn2+ but not of Cd2+. Channel blocker NS8593 reduced Co2+ and Mn2+ but not Cd2+ or Zn2+ cytotoxicity and interfered with Mg2+ loading as evaluated by TRPM7 channel basal activity. Ba2+ and Sr2+ were neither detectably toxic nor permeant through the plasma membrane. These results indicate that in Jurkat T cells, entry of toxic divalent metal cations primarily occurs through pathways distinct from TRPM7. By contrast, we found evidence that Mg2+ entry requires TRPM7 channels.

Entities:  

Keywords:  Amiloride; Cadmium; HAP1 cells; Immunotoxicity; Lanthanum; Metal toxicity; NS8593

Year:  2020        PMID: 32964285      PMCID: PMC7561021          DOI: 10.1007/s00424-020-02457-3

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  90 in total

1.  The biochemical effects of extracellular Zn(2+) and other metal ions are severely affected by their speciation in cell culture media.

Authors:  H Haase; S Hebel; G Engelhardt; L Rink
Journal:  Metallomics       Date:  2014-10-31       Impact factor: 4.526

2.  Regulation of vertebrate cellular Mg2+ homeostasis by TRPM7.

Authors:  Carsten Schmitz; Anne-Laure Perraud; Catherine O Johnson; Kazunori Inabe; Megan K Smith; Reinhold Penner; Tomohiro Kurosaki; Andrea Fleig; Andrew M Scharenberg
Journal:  Cell       Date:  2003-07-25       Impact factor: 41.582

3.  Natural and synthetic modulators of SK (K(ca)2) potassium channels inhibit magnesium-dependent activity of the kinase-coupled cation channel TRPM7.

Authors:  V Chubanov; M Mederos y Schnitzler; M Meißner; S Schäfer; K Abstiens; T Hofmann; T Gudermann
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

4.  Sphingosine and FTY720 are potent inhibitors of the transient receptor potential melastatin 7 (TRPM7) channels.

Authors:  Xin Qin; Zhichao Yue; Baonan Sun; Wenzhong Yang; Jia Xie; Eric Ni; Yi Feng; Rafat Mahmood; Yanhui Zhang; Lixia Yue
Journal:  Br J Pharmacol       Date:  2013-03       Impact factor: 8.739

5.  Regulation of Mg2+ Reabsorption and Transient Receptor Potential Melastatin Type 6 Activity by cAMP Signaling.

Authors:  Maxime G Blanchard; Wararat Kittikulsuth; Anil V Nair; Jeroen H F de Baaij; Femke Latta; Jonathan R Genzen; Donald E Kohan; René J M Bindels; Joost G J Hoenderop
Journal:  J Am Soc Nephrol       Date:  2015-07-06       Impact factor: 10.121

6.  Disruption of TRPM6/TRPM7 complex formation by a mutation in the TRPM6 gene causes hypomagnesemia with secondary hypocalcemia.

Authors:  Vladimir Chubanov; Siegfried Waldegger; Michael Mederos y Schnitzler; Helga Vitzthum; Martin C Sassen; Hannsjörg W Seyberth; Martin Konrad; Thomas Gudermann
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-19       Impact factor: 11.205

7.  Molecular determinants of sensitivity and conductivity of human TRPM7 to Mg2+ and Ca2+.

Authors:  Tomohiro Numata; Yasunobu Okada
Journal:  Channels (Austin)       Date:  2008-07-30       Impact factor: 2.581

8.  TRPM7 kinase activity is essential for T cell colonization and alloreactivity in the gut.

Authors:  Andrea Romagnani; Valentina Vettore; Tanja Rezzonico-Jost; Sarah Hampe; Elsa Rottoli; Wiebke Nadolni; Michela Perotti; Melanie A Meier; Constanze Hermanns; Sheila Geiger; Gunther Wennemuth; Camilla Recordati; Masayuki Matsushita; Susanne Muehlich; Michele Proietti; Vladimir Chubanov; Thomas Gudermann; Fabio Grassi; Susanna Zierler
Journal:  Nat Commun       Date:  2017-12-04       Impact factor: 14.919

9.  Inactivation of TRPM7 kinase in mice results in enlarged spleens, reduced T-cell proliferation and diminished store-operated calcium entry.

Authors:  Pavani Beesetty; Krystyna B Wieczerzak; Jennifer N Gibson; Taku Kaitsuka; Charles Tuan Luu; Masayuki Matsushita; J Ashot Kozak
Journal:  Sci Rep       Date:  2018-02-14       Impact factor: 4.379

10.  Mitochondrial Mg(2+) homeostasis decides cellular energy metabolism and vulnerability to stress.

Authors:  Ryu Yamanaka; Sho Tabata; Yutaka Shindo; Kohji Hotta; Koji Suzuki; Tomoyoshi Soga; Kotaro Oka
Journal:  Sci Rep       Date:  2016-07-26       Impact factor: 4.379

View more
  2 in total

1.  Phagocytic activity of splenic macrophages is enhanced and accompanied by cytosolic alkalinization in TRPM7 kinase-dead mice.

Authors:  Pavani Beesetty; Jananie Rockwood; Taku Kaitsuka; Tetyana Zhelay; Siham Hourani; Masayuki Matsushita; J Ashot Kozak
Journal:  FEBS J       Date:  2021-01-06       Impact factor: 5.622

2.  NSAIDs Naproxen, Ibuprofen, Salicylate, and Aspirin Inhibit TRPM7 Channels by Cytosolic Acidification.

Authors:  Rikki Chokshi; Orville Bennett; Tetyana Zhelay; J Ashot Kozak
Journal:  Front Physiol       Date:  2021-10-18       Impact factor: 4.566

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.